Author

Shrikant Anant

University of Kansas Medical CenterORCID 0000-0003-4193-3053Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

David StandingiD· 2 shared Michael P. WashburniD· 2 shared Roy A. JenseniD· 2 shared Andrea JewelliD· 1 shared Andrew K. GodwiniD· 1 shared Angela Kaczorowski-WorthleyiD· 1 shared Austin Morrison· 1 shared Avisha Pandey· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

David StandingORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyMolecular CancerPeer-reviewedFeb 24, 2025

DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma

Levi Arnold, Marrion Yap, Nathan Farrokhian…·Sufi Mary Thomas

This study identifies DCLK1's role in regulating invadopodia dynamics and MMP trafficking in HNSCC, showing its impact on invasion and metastasis.

8 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 26, 2024

Differential Remodeling of the BRCA1 Interactome by a Unique Minimal Clinical Truncation Mutation

Jingjing Chen, Mihaela E. Sardiu, Michaella J. Rekowski…·Roy A. Jensen

The paper identifies how the BRCA1-Y1853ter mutation alters protein interactions and cellular processes, suggesting gain-of-function effects in cancer.

DOI 10.1101/2024.11.26.625539

humanproteomics

𝕏 PostBluesky

Cancer BiologyCell Death and DiseasePeer-reviewedMay 25, 2024

IRAK1 is a critical mediator of low molecular weight hyaluronic acid-induced stemness in high-grade serous ovarian cancer

David Standing, Prasad R. Dandawate, Sumedha Gunewardena…·Shrikant Anant

This study identifies IRAK1 as a key mediator of LMW HA-induced stemness in EOC, showing its role in chemoresistance and demonstrating TCS2210 as a potential inhibitor.

10 citations

humanproteomics

𝕏 PostBluesky